Ørsted A/S (OTCMKTS:DNNGY – Get Free Report) was the target of a large decline in short interest in the month of October. As of October 15th, there was short interest totaling 117,425 shares, a decline of 35.2% from the September 30th total of 181,104 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 262,237 shares, the short-interest ratio is currently 0.4 days.
Ørsted A/S Price Performance
OTCMKTS DNNGY opened at $6.55 on Monday. Ørsted A/S has a 1 year low of $5.75 and a 1 year high of $9.04. The business’s 50-day moving average is $6.76 and its 200 day moving average is $7.53.
Wall Street Analysts Forecast Growth
DNNGY has been the subject of a number of analyst reports. Royal Bank Of Canada raised Ørsted A/S to a “moderate buy” rating in a research note on Tuesday, September 1st. The Goldman Sachs Group downgraded shares of Ørsted A/S from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 13th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.
Read Our Latest Analysis on DNNGY
About Ørsted A/S
Ørsted A/S is a Danish renewable energy company focused primarily on developing, constructing, owning and operating offshore wind farms. Its activities also include onshore wind, solar power, energy storage and other renewable energy projects, as well as related operations and maintenance services.
The company was established in 1972 as Dansk Naturgas, later known as DONG Energy, and initially operated across oil, natural gas and conventional energy markets. Following a strategic transition away from fossil fuels, the company adopted the name Ørsted in 2017 to reflect its focus on renewable energy.
Read More
- Five stocks we like better than Ørsted A/S
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Ørsted A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ørsted A/S and related companies with MarketBeat.com's FREE daily email newsletter.
